Cancer vaccines: toward the next breakthrough in cancer immunotherapy

Y Igarashi, T Sasada - Journal of immunology research, 2020 - Wiley Online Library
Until now, three types of well‐recognized cancer treatments have been developed, ie,
surgery, chemotherapy, and radiotherapy; these either remove or directly attack the cancer …

[HTML][HTML] Role of transforming growth factor-β superfamily signaling pathways in human disease

KJ Gordon, GC Blobe - Biochimica et Biophysica Acta (BBA)-Molecular …, 2008 - Elsevier
Transforming growth factor β (TGF-β) superfamily signaling pathways are ubiquitous and
essential regulators of cellular processes including proliferation, differentiation, migration …

Whole tumor antigen vaccines: where are we?

CLL Chiang, G Coukos, LE Kandalaft - Vaccines, 2015 - mdpi.com
With its vast amount of uncharacterized and characterized T cell epitopes available for
activating CD4+ T helper and CD8+ cytotoxic lymphocytes simultaneously, whole tumor …

Gene therapy for cancer treatment: past, present and future

D Cross, JK Burmester - Clinical medicine & research, 2006 - Marshfield Clinic
The broad field of gene therapy promises a number of innovative treatments that are likely to
become important in preventing deaths from cancer. In this review, we discuss the history …

Recent progress in GM-CSF-based cancer immunotherapy

WL Yan, KY Shen, CY Tien, YA Chen, SJ Liu - Immunotherapy, 2017 - Taylor & Francis
Cancer immunotherapy is a growing field. GM-CSF, a potent cytokine promoting the
differentiation of myeloid cells, can also be used as an immunostimulatory adjuvant to elicit …

Prostate cancer as a model for tumour immunotherapy

CG Drake - Nature Reviews Immunology, 2010 - nature.com
Advances in basic immunology have led to an improved understanding of the interactions
between the immune system and tumours, generating renewed interest in approaches that …

[HTML][HTML] Human T regulatory cell therapy: take a billion or so and call me in the morning

JL Riley, CH June, BR Blazar - Immunity, 2009 - cell.com
Immune system regulation is of paramount importance to host survival. In settings of
autoimmunity and alloimmunity, control is lost, resulting in injury to vital organs and tissues …

Therapeutic cancer vaccines: are we there yet?

CA Klebanoff, N Acquavella, Z Yu… - Immunological …, 2011 - Wiley Online Library
Enthusiasm for therapeutic cancer vaccines has been rejuvenated with the recent
completion of several large, randomized phase III clinical trials that in some cases have …

Targeting the transforming growth factor-β signaling pathway in human cancer

NS Nagaraj, PK Datta - Expert opinion on investigational drugs, 2010 - Taylor & Francis
The transforming growth factor-ß (TGF-β) signaling pathway plays a pivotal role in diverse
cellular processes. TGF-β switches its role from a tumor suppressor in normal or dysplastic …

Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines

M Oladejo, W Paulishak, L Wood - Seminars in Cancer Biology, 2023 - Elsevier
Cancer vaccines and immune checkpoint inhibitors (ICIs) function at different stages of the
cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer …